Skip to main content

Table 3 Overview of arm function and quality of life test results using intention to treat analysis (N = 12)

From: HoMEcare aRm rehabiLItatioN (MERLIN): telerehabilitation using an unactuated device based on serious games improves the upper limb function in chronic stroke

Outcome measures

Mean ± SD

Post hoc analysis

T0

T1

T2

T3

p-value

WMFT FAS

48.00 ± 10.41

49.58 ± 11.95

52.96 ± 12.24

53.38 ± 14.08

T0–T2 = 0.003

T1–T3 = 0.006

WMFT time

23.65 ± 23.91

24.27 ± 24.97

21.86 ± 19.74

24.24 ± 24.89

 

FMA-UE total

36.33 ± 7.83

37.58 ± 9.38

43.17 ± 11.20

44.75 ± 11.33

T0–T2 = 0.004

T0–T3 =  < 0.001

T1–T2 = 0.003

T1–T3 =  < 0.001

FMA-UE Shoulder

21.5 ± 3.92

21.92 ± 4.27

24.92 ± 5.74

25.92 ± 5.47

T0–T3 = 0.002

T1–T2 = 0.005

T1–T3 =  < 0.001

FMA-UE Wrist

5.67 ± 2.93

5.0 ± 2.30

5.46 ± 2.57

6.04 ± 2.72

T1–T3 = 0.004

FMA-UE Hand

6.17 ± 3.27

7.17 ± 3.88

8.38 ± 4.27

8.21 ± 4.35

T0–T2 = 0.003

FMA-UE Coordination/speed

3.0 ± 1.41

3.5 ± 1.24

4.42 ± 1.16

4.58 ± 1.16

T0–T2 = 0.003

T0–T3 = 0.003

T1–T3 = 0.005

ARAT

27.33 ± 13.47

27.83 ± 15.03

32.25 ± 17.09

31.50 ± 17.68

T1–T2 = 0.007

EQ-5D health state

0.70 ± 0.13

0.73 ± 0.13

0.76 ± 0.08

0.74 ± 0.10

 

EQ-5D VAS

73.75 ± 18.23

70.08 ± 17.27

79.75 ± 16.23

73.92 ± 15.97

 
  1. Repeated measures ANOVA with post hoc analysis. Only significant differences are shown, significant difference = p < 0.008
  2. ARAT Action Research Arm Test, EQ-5D EurQoL–5 Dimensions, FAS Functional Ability Scale, FMA-UE Fugl-Meyer Assessment-Upper Extremity, SD standard deviation, VAS Visual Analogue Scale, WMFT Wolf Motor Function Test